A critical review on the use of recombinant factor VIIa in life-threatening obstetric postpartum hemorrhage.

Abstract

The objective of this review was to evaluate and summarize the current literature on the unlicensed use of the novel agent recombinant activated factor VII (rFVIIa) in the management of major postpartum hemorrhage. After a systematic electronic search without temporal limits on MEDLINE, EMBASE, OVID and SCOPUS, the bibliographic references of all retrieved… (More)
DOI: 10.1055/s-2008-1066022

Topics

  • Presentations referencing similar topics